{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:06Z","timestamp":1792182306995,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T00:00:00Z","timestamp":1390176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/aps.2013.135","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T10:02:13Z","timestamp":1390212133000},"page":"363-372","source":"Crossref","is-referenced-by-count":40,"title":["Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats"],"prefix":"10.1038","volume":"35","author":[{"given":"Li-fang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-man","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-juan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-ye","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,20]]},"reference":[{"key":"BFaps2013135_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1528-1157.1975.tb04738.x","volume":"16","author":"D Simon","year":"1975","unstructured":"Simon D, Penry JK . Sodium Di-N-propylacetate (DPA) in the treatment of epilepsy. Epilepsia 1975; 16: 549\u201373.","journal-title":"Epilepsia"},{"key":"BFaps2013135_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0301-0082(82)90010-7","volume":"19","author":"A Chapman","year":"1982","unstructured":"Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC . Mechanism of anticonvulsant action of valproate. Prog Neurobiol 1982; 19: 315\u201359.","journal-title":"Prog Neurobiol"},{"key":"BFaps2013135_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-4598-4-22","volume":"4","author":"A Chavez-Blanco","year":"2005","unstructured":"Chavez-Blanco A, Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Cetina L, Candelaria M . Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study. Mol Cancer 2005; 4: 22.","journal-title":"Mol Cancer"},{"key":"BFaps2013135_CR4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1182\/blood-2009-11-249474","volume":"116","author":"O Goodyear","year":"2010","unstructured":"Goodyear O, Agathanggelou A, Novitzky-Basso I, Siddique S, McSkeane T, Ryan G, et al. Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Blood 2010; 116: 1908\u201318.","journal-title":"Blood"},{"key":"BFaps2013135_CR5","first-page":"85","volume":"3","author":"MJ Eadie","year":"1988","unstructured":"Eadie MJ, Hooper WD, Dickinson RG . Valproate-associated hepatotoxicity and its biochemical mechanisms. Med Toxicol Adverse Drug Exp 1988; 3: 85\u2013106.","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"BFaps2013135_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/toxsci\/kfi184","volume":"86","author":"V Tong","year":"2005","unstructured":"Tong V, Teng XW, Chang TK, Abbott FS . Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci 2005; 86: 427\u201335.","journal-title":"Toxicol Sci"},{"key":"BFaps2013135_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.20074","volume":"55","author":"GJ Luef","year":"2004","unstructured":"Luef GJ, Waldmann M, Sturm W, Naser A, Trinka E, Unterberger I, et al. Valproate therapy and nonalcoholic fatty liver disease. Ann Neurol 2004; 55: 729\u201332.","journal-title":"Ann Neurol"},{"key":"BFaps2013135_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"CM Becker","year":"1983","unstructured":"Becker CM, Harris RA . Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys 1983; 223: 381\u201392.","journal-title":"Arch Biochem Biophys"},{"key":"BFaps2013135_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0006-291X(83)80205-8","volume":"115","author":"FX Coud\u00e9","year":"1983","unstructured":"Coud\u00e9 FX, Grimber G, Pelet A, Benoit Y . Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochem Biophys Res Commun 1983; 115: 730\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFaps2013135_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1023\/A:1007649815992","volume":"15","author":"D Pessayre","year":"1999","unstructured":"Pessayre D, Mansouri A, Haouzi D, Fromenty B . Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367\u201373.","journal-title":"Cell Biol Toxicol"},{"key":"BFaps2013135_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1124\/jpet.107.131185","volume":"324","author":"AC Knapp","year":"2008","unstructured":"Knapp AC, Todesco L, Beier K, Terracciano L, S\u00e4gesser H, Reichen J, et al. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores. J Pharmacol Exp Ther 2008; 324: 568\u201375.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps2013135_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1128\/AAC.35.9.1729","volume":"35","author":"T Oguma","year":"1991","unstructured":"Oguma T, Yamada H, Sawaki M, Narita N . Pharmacokinetic analysis of the effects of different foods on absorption of cefaclor. Antimicrob Agents Chemother 1991; 35: 1729\u201335.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFaps2013135_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3945\/ajcn.110.000950","volume":"93","author":"A OSullivan","year":"2011","unstructured":"OSullivan A, Gibney MJ, Brennan L . Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 2011; 93: 314\u201321.","journal-title":"Am J Clin Nutr"},{"key":"BFaps2013135_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2002","unstructured":"Bellentani S, Saccoccio G, Masutti F, Croc\u00e8 LS, Brandi G, Sasso F . Prevalence and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2002; 132: 112\u20137.","journal-title":"Ann Intern Med"},{"key":"BFaps2013135_CR15","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","volume":"48","author":"NM de Alwis","year":"2008","unstructured":"de Alwis NM, Day CP . Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48: S104\u201312.","journal-title":"J Hepatol"},{"key":"BFaps2013135_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1006\/pmed.2002.1018","volume":"34","author":"J Satia-Abouta","year":"2002","unstructured":"Satia-Abouta J, Patterson RE, Schiller RN, Kristal AR . Energy from fat is associated with obesity in US men: results from the Prostate Cancer Prevention Trial. Prev Med 2002; 34: 493\u2013501.","journal-title":"Prev Med"},{"key":"BFaps2013135_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","volume":"50","author":"JG Fan","year":"2009","unstructured":"Fan JG, Farrell GC . Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204\u201310.","journal-title":"J Hepatol"},{"key":"BFaps2013135_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P . Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221\u201331.","journal-title":"N Engl J Med"},{"key":"BFaps2013135_CR19","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1021\/pr800352k","volume":"7","author":"H Li","year":"2011","unstructured":"Li H, Xie Z, Lin J, Song H, Wang Q, Wang K, et al. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. J Proteome Res 2011; 7: 4775\u201383.","journal-title":"J Proteome Res"},{"key":"BFaps2013135_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","volume":"52","author":"RS Rector","year":"2010","unstructured":"Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 2010; 52: 727\u201336.","journal-title":"J Hepatol"},{"key":"BFaps2013135_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.yebeh.2010.12.012","volume":"20","author":"A Verrotti","year":"2011","unstructured":"Verrotti A, Agostinelli S, Parisi P, Chiarelli F, Coppola G . Nonalcoholic fatty liver disease in adolescents receiving valproic acid. Epilepsy Behav 2011; 20: 382\u20135.","journal-title":"Epilepsy Behav"},{"key":"BFaps2013135_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson JK, Lindon JC, Holmes E . 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181\u20139.","journal-title":"Xenobiotica"},{"key":"BFaps2013135_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrd728","volume":"1","author":"JK Nicholson","year":"2002","unstructured":"Nicholson JK, Connelly J, Lindon JC, Holmes E . Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"BFaps2013135_CR24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bmc.1279","volume":"24","author":"AJY Gu SH","year":"2010","unstructured":"Gu SH, A JY, Wang GJ, Zha WB, Yan B, Zhang Y, et al. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia. Biomed Chromatoqr 2010; 24: 245\u201352.","journal-title":"Biomed Chromatoqr"},{"key":"BFaps2013135_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/omi.2006.10.1","volume":"10","author":"LK Schnackenberg","year":"2006","unstructured":"Schnackenberg LK, Jones RC, Thyparambil S, Taylor JT, Han T, Tong W, et al. An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms. OMICS 2006; 10: 1\u201314.","journal-title":"OMICS"},{"key":"BFaps2013135_CR26","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1021\/pr1002593","volume":"9","author":"J Barr","year":"2010","unstructured":"Barr J, Vazquez-Chantada M, Alonso C, Perez-Cormenzana M, Mayo R, Gal\u00e1n A, et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res 2010; 9: 4501\u201312.","journal-title":"J Proteome Res"},{"key":"BFaps2013135_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","volume":"220","author":"MH Lee","year":"2007","unstructured":"Lee MH, Hong I, Kim M, Lee BH, Kim JH, Kang KS, et al. Gene expression profiles of murine fatty liver induced by the administration of valproic acid. Toxicol Appl Pharmacol 2007; 220: 45\u201359.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFaps2013135_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E . Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002; 16: 695\u2013714.","journal-title":"CNS Drugs"},{"key":"BFaps2013135_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.taap.2007.09.014","volume":"226","author":"MH Lee","year":"2008","unstructured":"Lee MH, Kim M, Lee BH, Kim JH, Kang KS, Kim HL, et al. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver. Toxicol Appl Pharmacol 2008; 226: 271\u201384.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFaps2013135_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/004982500433309","volume":"30","author":"H Hakk","year":"2000","unstructured":"Hakk H, Larsen G, Bergman A, Orn U . Metabolism, excretion and distribution of the flame retardant tetrabromobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 2000; 30: 881\u201390.","journal-title":"Xenobiotica"},{"key":"BFaps2013135_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3109\/00498254.2011.565819","volume":"41","author":"D Bachir-Cherif","year":"2011","unstructured":"Bachir-Cherif D, Blum D, Braendli-Baiocco A, Chaput E, Pacheco GC, Flint N, et al. Characterization of post-surgical alterations in the bile duct-cannulated rat. Xenobiotica 2011; 41: 701\u201311.","journal-title":"Xenobiotica"},{"key":"BFaps2013135_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ab.2008.04.025","volume":"379","author":"JY A","year":"2008","unstructured":"A JY, Hang Q, Wang GJ, Zha WB, Yan B, Ren H, et al. Global analysis of metabolites in rat and human urine based on gas chromatography\/time-of-flight mass spectrometry. Anal Biochem 2008; 379: 20\u20136.","journal-title":"Anal Biochem"},{"key":"BFaps2013135_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ab.2010.07.015","volume":"406","author":"LS Liu","year":"2010","unstructured":"Liu LS, A JY, Wang GJ, Yan B, Zhang Y, Wang X, et al. Differences in metabolite profile between blood plasma and serum. Anal Biochem 2010; 406: 105\u201312.","journal-title":"Anal Biochem"},{"key":"BFaps2013135_CR34","doi-asserted-by":"publisher","first-page":"M110.004945","DOI":"10.1074\/mcp.M110.004945","volume":"10","author":"T Chen","year":"2011","unstructured":"Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics 2011; 10: M110.004945.","journal-title":"Mol Cell Proteomics"},{"key":"BFaps2013135_CR35","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1021\/ac051211v","volume":"77","author":"J A","year":"2005","unstructured":"A J, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, et al. Extraction and GC\/MS analysis of the human blood plasma metabolome. Anal Chem 2005; 77: 8086\u201394.","journal-title":"Anal Chem"},{"key":"BFaps2013135_CR36","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1021\/ac050601e","volume":"77","author":"P Jonsson","year":"2005","unstructured":"Jonsson P, Johansson AI, Gullberg J, Trygg J, A JY, Grung B, et al. High-throughput data analysis for detecting and identifying differences between samples in GC\/MS-based metabolomic analyses. Anal Chem 2005; 77: 5635\u201342.","journal-title":"Anal Chem"},{"key":"BFaps2013135_CR37","unstructured":"Eriksson L, Johansson E, Kettaneh-Wold N . Multi- and megavariate data analysis principles and applications. 2001. Umetrics, Ume, Sweden."},{"key":"BFaps2013135_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/pr060594q","volume":"6","author":"J Trygg","year":"2007","unstructured":"Trygg J, Holmes E, Lundstedt T . Chemometrics in metabonomics. J Proteome Res 2007; 6: 469\u201379.","journal-title":"J Proteome Res"},{"key":"BFaps2013135_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/lsm.1048","volume":"28","author":"C Eker","year":"2001","unstructured":"Eker C, Rydell R, Svanberg K, Andersson-Engels S . Multivariate analysis of laryngeal fluorescence spectra recorded in vivo. Lasers Surg Med 2001; 28: 259\u201366.","journal-title":"Lasers Surg Med"},{"key":"BFaps2013135_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejphar.2013.09.024","volume":"721","author":"LF Zhang","year":"2013","unstructured":"Zhang LF, Chu XM, Wang H, Xie H, Guo C, Cao LJ, et al. Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver. Eur J Pharmacol 2013; 721: 277\u201385.","journal-title":"Eur J Pharmacol"},{"key":"BFaps2013135_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-8278(97)80496-5","volume":"26","author":"B Fromenty","year":"1997","unstructured":"Fromenty B, Pessayre D . Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997; 26: 43\u201353.","journal-title":"J Hepatol"},{"key":"BFaps2013135_CR42","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/0006-2952(92)90324-C","volume":"43","author":"S Ponchault","year":"1992","unstructured":"Ponchault S, van Hoof F, Veitch K . In vitro effects of valproate and valproate metabolites on mitochondrial oxidations: relevance of CoA sequestration to the observed inhibitions. Biochem Pharmacol 1992; 43: 2435\u201342.","journal-title":"Biochem Pharmacol"},{"key":"BFaps2013135_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0009-2797(01)00234-4","volume":"137","author":"MF Silva","year":"2001","unstructured":"Silva MF, Ruiter JP, IJlst L, Jakobs C, Duran M, de Almeida IT, et al. Differential effect of valproate and its D2-and D4-unsaturated metabolites, on the b-oxidation rate of long-chain and medium-chain fatty acids. Chem-Biol Interact 2001; 137: 203\u201312.","journal-title":"Chem-Biol Interact"},{"key":"BFaps2013135_CR44","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00125-007-0738-5","volume":"50","author":"AA Toye","year":"2007","unstructured":"Toye AA, Dumas ME, Blancher C, Rothwell AR, Fearnside JF, Wilder SP, et al. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 2007; 50: 1867\u201379.","journal-title":"Diabetologia"},{"key":"BFaps2013135_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.metabol.2009.08.022","volume":"59","author":"Z Xie","year":"2010","unstructured":"Xie Z, Li H, Wang K, Lin J, Wang Q, Zhao G, et al. Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat. Metabolism 2010; 59: 54\u201360.","journal-title":"Metabolism"},{"key":"BFaps2013135_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"CM Becker","year":"1983","unstructured":"Becker CM, Harris RA . Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys 1983; 223: 381\u201392.","journal-title":"Arch Biochem Biophys"},{"key":"BFaps2013135_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tiv.2012.01.020","volume":"26","author":"J Pourahmad","year":"2012","unstructured":"Pourahmad J, Eskandari MR, Kaghazi A, Shaki F, Shahraki J, Fard JK . A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis. Toxicol In Vitro 2012; 26: 545\u201351.","journal-title":"Toxicol In Vitro"},{"key":"BFaps2013135_CR48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/hep.510250127","volume":"25","author":"L Kr\u00e4henb\u00fchl","year":"1997","unstructured":"Kr\u00e4henb\u00fchl L, Reichen J, Talos C, Kr\u00e4henb\u00fchl S . Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis. Hepatology 1997; 25: 278\u201383.","journal-title":"Hepatology"},{"key":"BFaps2013135_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF03179889","volume":"59","author":"J Pie","year":"2003","unstructured":"Pie J, Casals N, Puisac B, Hegardt FG . Molecular basis of 3-hydroxy-3-methylglutaric aciduria. J Physiol Biochem 2003; 59: 311\u201321.","journal-title":"J Physiol Biochem"},{"key":"BFaps2013135_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-2000-10043","volume":"212","author":"S Koling","year":"2000","unstructured":"Koling S, Kalhoff H, Schauerte P, Lehnert W, Diekmann L . 3-hydroxy-3- methylglutaraciduria (case report of a female Turkish sisters with 3-hydroxy-3- methylglutaryl- Coenzyme A lyase deficiency. Klin Padiatr 2000; 212: 113\u20136.","journal-title":"Klin Padiatr"},{"key":"BFaps2013135_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ejlt.200600015","volume":"108","author":"B Batetta","year":"2006","unstructured":"Batetta B, Sanna F . Cholesterol metabolism during cell growth: Which role for the plasma membrane? Eur J Lipid Sci Technol 2006; 108: 687\u201399.","journal-title":"Eur J Lipid Sci Technol"},{"key":"BFaps2013135_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0021-9150(01)00677-3","volume":"161","author":"D Sviridov","year":"2002","unstructured":"Sviridov D, Nestel P . Dynamics of reverse cholesterol transport: Protection against atherosclerosis. Atherosclerosis 2002; 161: 245\u201354.","journal-title":"Atherosclerosis"},{"key":"BFaps2013135_CR53","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.3748\/wjg.14.5641","volume":"14","author":"A Esteller","year":"2008","unstructured":"Esteller A . Physiology of bile secretion. World J Gastroenterol 2008; 14: 5641\u20139.","journal-title":"World J Gastroenterol"},{"key":"BFaps2013135_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13105-010-0061-3","volume":"67","author":"J Kolodziejczyk","year":"2011","unstructured":"Kolodziejczyk J, Saluk-Juszczak J, Wachowicz B . In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. J Physiol Biochem 2011; 67: 175\u201383.","journal-title":"J Physiol Biochem"},{"key":"BFaps2013135_CR55","first-page":"1337","volume":"46","author":"IT Mak","year":"2000","unstructured":"Mak IT, Komarov AM, Kramer JH, Weglicki WB . Protective mechanisms of Mg-gluconate against oxidative endothelial cytotoxicity. Cell Mol Biol 2000; 46: 1337\u201344.","journal-title":"Cell Mol Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2013135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2013135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2013135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:12:52Z","timestamp":1746115972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2013135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,20]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFaps2013135"],"URL":"https:\/\/doi.org\/10.1038\/aps.2013.135","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,20]]}}}